31 julho 2020
COVID-19 Guidance and Resources
‘Coronationalism’ vs a geopolitical Europe?
On the one hand, the EU wishes to become a geopolitical power, which demands that the Union and its member states step up their supportive role on the global scene. On the other, there are signs of ‘coronationalism,’ with some national political parties questioning the timing of EU external aid when member states themselves are struggling.
Based on expert contributions from a representative cross-section of 13 member states, this paper delves into the question of whether and how external solidarity features in political and public discourse in Covid-struck Europe. It finds that, for now, neither coronationalist nor geopolitical ambitions dominate the relatively little politicised debates about international cooperation and development aid.
AstraZeneca to be exempt from coronavirus-vaccine liability claims in most countries
AstraZeneca to be exempt from coronavirus-vaccine liability claims in most countries: AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters.
With 25 companies testing their vaccine candidates on humans and getting ready to immunise hundred millions of people once the products are shown to work, the question of who pays for any claims for damages in case of side effects has been a tricky point in supply negotiations.
“This is a unique situation where we as a company simply cannot take the risk if in ... four years the vaccine is showing side effects,” Ruud Dobber, a member of Astra’s senior executive team, told Reuters.
“In the contracts we have in place, we are asking for indemnification. For most countries it is acceptable to take that risk on their shoulders because it is in their national interest,” he said, adding that Astra and regulators were making safety and tolerability a top priority.
Dobber would not name the countries.
EU officials told Reuters this week product liability was among contentious points in European efforts to secure supply deals for potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson.
Compulsory licensing and access to future Covid-19 vaccines
Exploiting isolation: sexual predators increasingly targeting children during COVID pandemic
30 julho 2020
How Will a Coronavirus Vaccine Work?
-
The dangers of Covid-19 far outweigh the risks of a vaccine : So can I tell you that there won't be a long-term unknown side effect to t...
-
The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
-
The Oxford/AstraZeneca Vaccine Efficacy Data : We’re going to have to wait and collect more data to be able to say anything about these, fo...